Clinical Trials Logo

Muscle Hypotonia clinical trials

View clinical trials related to Muscle Hypotonia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06409377 Completed - Dexmedetomidine Clinical Trials

Effect of Dexmedetomidine on Improving Intubating Conditions Without the Use of Muscle Relaxant

Start date: February 25, 2024
Phase: Phase 4
Study type: Interventional

Tracheal intubation is usually facilitated by the administration of anesthetic drugs including a muscle relaxant. Over the past few years, several factors have led researchers to consider omitting neuromuscular blocking agents for tracheal intubation. (1, 2) Despite the frequent use of NMBAs in clinical practice, side effects associated with NMBA use can be particularly concerning such as anaphylaxis, cardiovascular effects related to histamine release or sympathomimetic properties, Bronchospasm, and prolonged paralysis. (3) Therefore, many studies (4, 5) focused on the possibility of performing tracheal intubation without the use of neuromuscular blocking agents. The challenge was to find the correct choice and dose of induction agent, opioid, or adjuvant drug to produce adequate intubating conditions without cardiovascular side effects. Dexmedetomidine is a potent and highly selective alpha-2 receptor agonist with sympatholytic, sedative, amnestic, and analgesic properties. It inhibits sympathetic activity thus terminating the pain signals and thereby blunts the pressor response associated with laryngoscopy and endotracheal intubation.

NCT ID: NCT06060197 Completed - Clinical trials for Allan-Herndon-Dudley Syndrome

MCT8 Deficiency Caregiver Study

Start date: August 23, 2022
Phase:
Study type: Observational

Caregivers face many responsibilities outside of their role as a friend or parent, which can lead to emotional, financial, social, and professional challenges. To better understand the impact of MCT8 deficiency on caregivers, Egetis Therapeutics are conducting an online survey for adult caregivers of persons living with the MCT8 deficiency.

NCT ID: NCT05440058 Completed - Anesthesia Clinical Trials

BIS Monitoring in Relation to Muscle Relaxant Administration

Start date: August 26, 2022
Phase:
Study type: Observational

The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.

NCT ID: NCT05432570 Completed - Clinical trials for Intubation; Difficult or Failed

Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

Neuromuscular blockers provide muscle relaxation by blocking the electrical conduction to motor nerves and facilitate endotracheal tube placement while relaxing the whole body for surgical comfort during general anesthesia. Parotid surgery is a procedure performed by ear, nose and throat physicians, and as a complication during this procedure, permanent facial paralysis may develop due to damage to the facial nerve. Intraoperative nerve monitoring is frequently used to avoid this complication. The application of local anesthetic to the vocal cords and into the trachea has been tried and found useful for induction of anesthesia without the use of neuromuscular blockers. In studies conducted with this technique, a standard local anesthetic dose was not specified and local anesthetics were generally administered alone and in high doses. It is expected that anesthesia induction and intubation without the use of muscle relaxants will not affect the comfort of the patient and the procedure, but will increase the surgical time and surgical satisfaction.

NCT ID: NCT05391594 Completed - Cerebral Palsy Clinical Trials

Effect of Trunk Support on Academic Engagement of Children With Severe Disability

Start date: May 31, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of optimizing trunk support based on segmental principles of trunk control, on academic engagement of children in academic settings.

NCT ID: NCT05310110 Completed - Anesthesia, General Clinical Trials

Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly

LMA
Start date: April 12, 2022
Phase: N/A
Study type: Interventional

Laryngeal mask airway (LMA) is currently the most widely used supraglottic airway device with advantages of simple and fast placement, reduced anesthesia drug use, more stable hemodynamics, and less throat discomfort after anesthesia compared to endotracheal intubation. Some studies claimed the use of muscle relaxants or local anesthetics (sprays or lubricants containing local anesthetics) for the throat before LMA placement can reduce the dosage of induction agents and postoperative throat complications. In modern society, more and more elderly people undergo elective surgery with the need of general anesthesia. However, they are the more vulnerable population with tendency of greater hemodynamic changes with more induction agent usage. Propofol is one of the most used induction agents which may lead to a drop in blood pressure. The objective of this study is to observe whether the dose of propofol and the changes in hemodynamics can be reduced by using muscle relaxants or laryngeal local anesthetics in elderly who receiving general anesthesia with LMA insertion.

NCT ID: NCT05131542 Completed - Down Syndrome Clinical Trials

Assessment of Hypotonia in Children With Down Syndrome

Start date: April 1, 2019
Phase:
Study type: Observational

Hypotonia is a common trait in infants with Down syndrome, resulting in pathologies and delays in gaining basic motor skills. There are no screenings available to aid in early diagnosis, therefore, the purpose of this study is to develop a way to test for hypotonia in children with Down syndrome.

NCT ID: NCT05097508 Completed - Clinical trials for Entropy Device and How Will Muscle Relaxants Affect it

Effect of Atracurium and Rocuronium on the State and Response Entropy During Isoflurane Anesthesia

Start date: June 20, 2020
Phase: Early Phase 1
Study type: Interventional

Many studies have explored the effects of inhalation anesthetics, intravenous anesthetics, and muscle relaxants on spectral entropy, but most did not monitor the degree of neuromuscular block. In addition, they do not explore the effects of different degrees of neuromuscular blockade on spectral entropy under different concentrations of isoflurane inhalation. Therefore, the present study will evaluate different levels of MAC to quantify the isoflurane concentration, as well as different degrees of neuromuscular blockade

NCT ID: NCT04894799 Completed - Cerebral Palsy Clinical Trials

Vestibular Stimulation and Neurodevelopmental Technique on Hypotonic Cerebral Palsy While Controlling the Gender

Start date: May 30, 2021
Phase: N/A
Study type: Interventional

there is no such article found who specifies the effects of sensory integration therapies like vestibular stimulation technique or developmental milestone while controlling the gender of children with cerebral palsy. So, there is a need to do more research work on this in future to find out best treatment approach for children with cerebral palsy of their respective gender. That is why this study will focus on the results of vestibular stimulation and neurodevelopmental technique while controlling the Gender distribution of both intervention groups to find out the effects of these interventions that wither, they have some influence on the participants or not.

NCT ID: NCT04846400 Completed - Clinical trials for Sleep Apnea, Obstructive

Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia

ssNPA
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

Children with hypotonic upper airway obstruction have a high prevalence of severe obstructive sleep apnea, which if not treated has significant clinical consequence. Available treatment approaches, such as surgery and positive airway pressure, show limited efficacy and adherence. The multidisciplinary team has developed and now proposes to further test a non-surgical, well-tolerated nasopharyngeal airway device that in initial patients has resolved even extremely severe obstructive sleep apnea, and improved patient and family quality of life.